Katja Kjær Grønbæk, MD PhD student
Rigshospitalet og Bispebjerg Hospital
Adult high-risk patients (from 18 years of age) acutely admitted with i.e. sepsis, dyspnea, heart failure, ACS or pneumonia
Included patients will be monitored with WARD equipment after hospital admission and will be monitored during hospitalization. Patients will be randomized to receive either standard treatment where WARD study-data are blinded to the healthcare professionals (nurses etc.) treating the patient (control group) or will have real-time continuous monitored vital parameter data transferred to an alarm-generating App (WARD-CSS) in case of vital parameter deviations, that the nurse responsible for the patient care can access through a provided WARD smartphone (case group).
Primary outcome is the amount and duration of physiological parameter deviations between the two groups.
– Read more
